Skip to content

CHELSEA THERAPEUTICS INTERNATIONAL, LTD.: 10-Q filed 2012-08-07

What CHELSEA THERAPEUTICS INTERNATIONAL, LTD. reported in its quarterly report filed 2012-08-07 (fiscal Q2 2012): 26 published measures, 81 facts as tagged in accession 0001144204-12-043342.

This filing

Form
10-Q (quarterly report)
Filed
2012-08-07
Fiscal period
fiscal Q2 2012
Accession
0001144204-12-043342 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHELSEA THERAPEUTICS INTERNATIONAL, LTD. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-06-3042,390,725USD
At 2011-12-3146,902,705USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-06-308,723,878USD
At 2011-12-3113,237,895USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-06-3033,666,847USD
At 2011-12-3133,664,810USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-06-3040,823,594USD
At 2011-12-3141,106,301USD
At 2011-06-3010,966,999USD
At 2011-01-0147,593,055USD
At 2010-12-3147,593,055USD
At 2002-04-020USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-7,872,285USD91
2012-01-01 to 2012-06-30-23,431,502USD182
2002-04-03 to 2012-06-30-206,757,004USD3742
2011-04-01 to 2011-06-30-13,271,387USD91
2011-01-02 to 2011-06-30-27,139,593USD180

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-06-30-26,949,704USD182
2002-04-03 to 2012-06-30-187,551,202USD3742
2011-01-02 to 2011-06-30-26,512,428USD180

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-06-3023,121USD182
2002-04-03 to 2012-06-30737,594USD3742
2011-01-02 to 2011-06-30140,516USD180

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-06-3022,151,851USD182
2002-04-03 to 2012-06-30229,108,713USD3742
2011-01-02 to 2011-06-3046,172,107USD180

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-06-304,515,146USD182
2002-04-03 to 2012-06-30-733,917USD3742
2011-01-02 to 2011-06-30-56,285,735USD180

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-06-30246,029USD
At 2011-12-31291,024USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-06-301,281,688USD182
2002-04-03 to 2012-06-3010,272,344USD3742
2011-01-02 to 2011-06-301,347,002USD180

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-7,889,879USD91
2012-01-01 to 2012-06-30-23,477,870USD182
2002-04-03 to 2012-06-30-211,486,543USD3742
2011-04-01 to 2011-06-30-13,322,703USD91
2011-01-02 to 2011-06-30-27,225,491USD180

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-06-3042,144,696USD
At 2011-12-3146,573,414USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-04-01 to 2012-06-300USD91
2012-01-01 to 2012-06-300USD182
2002-04-03 to 2012-06-30258,348USD3742
2011-04-01 to 2011-06-300USD91
2011-01-02 to 2011-06-300USD180

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-06-302,174,401USD
At 2011-12-314,866,356USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-04-01 to 2012-06-307,889,879USD91
2012-01-01 to 2012-06-3023,477,870USD182
2002-04-03 to 2012-06-30211,486,543USD3742
2011-04-01 to 2011-06-3013,322,703USD91
2011-01-02 to 2011-06-3027,225,491USD180

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-04-01 to 2012-06-304,695,546USD91
2012-01-01 to 2012-06-3013,394,664USD182
2002-04-03 to 2012-06-30159,155,088USD3742
2011-04-01 to 2011-06-3010,681,032USD91
2011-01-02 to 2011-06-3022,139,974USD180

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-06-3067,040,569shares
At 2011-12-3162,034,146shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-06-30240,417,146USD
At 2011-12-31216,984,108USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-06-300USD
At 2011-12-3138,267USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-06-304,784,609USD
At 2011-12-315,245,339USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-06-30651,162USD
At 2011-12-31793,521USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-04-01 to 2012-06-301,441,167USD91
2012-01-01 to 2012-06-303,361,278USD182
2002-04-03 to 2012-06-3028,584,951USD3742
2011-04-01 to 2011-06-301,317,454USD91
2011-01-02 to 2011-06-302,650,170USD180

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-06-3068,115USD182
2002-04-03 to 2012-06-30490,094USD3742
2011-01-02 to 2011-06-3059,644USD180

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2012-01-01 to 2012-06-300USD182
2002-04-03 to 2012-06-30224,328USD3742
2011-01-02 to 2011-06-300USD180

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-06-3023,700,000USD182
2011-01-02 to 2011-12-3140,300,000USD364

Inspect the source

Entity
CHELSEA THERAPEUTICS INTERNATIONAL, LTD. / CIK 0001333763
Captured
SEC response SHA-256
354bb9243ece9eacb7fe265090cbbf659edca4a013cc87523793af082dfdb51c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001333763.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))